These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 8174137

  • 21. Variables influencing tumor uptake of anti-melanoma monoclonal antibodies radioiodinated using para-iodobenzoyl (PIB) conjugate.
    Murray JL, Mujoo K, Wilmanns C, Mansfield P, Wilbur DS, Rosenblum MG.
    J Nucl Med; 1991 Feb; 32(2):279-87. PubMed ID: 1992032
    [Abstract] [Full Text] [Related]

  • 22. Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR.
    Luwor RB, Johns TG, Murone C, Huang HJ, Cavenee WK, Ritter G, Old LJ, Burgess AW, Scott AM.
    Cancer Res; 2001 Jul 15; 61(14):5355-61. PubMed ID: 11454674
    [Abstract] [Full Text] [Related]

  • 23. Penetration and binding of antibodies in experimental human solid tumors grown in mice.
    Ong GL, Mattes MJ.
    Cancer Res; 1989 Aug 01; 49(15):4264-73. PubMed ID: 2743313
    [Abstract] [Full Text] [Related]

  • 24. Monoclonal antiidiotypic antibodies related to the p97 human melanoma antigen.
    Kahn M, Hellström I, Estin CD, Hellström KE.
    Cancer Res; 1989 Jun 15; 49(12):3157-62. PubMed ID: 2470502
    [Abstract] [Full Text] [Related]

  • 25. Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts.
    Fan Z, Baselga J, Masui H, Mendelsohn J.
    Cancer Res; 1993 Oct 01; 53(19):4637-42. PubMed ID: 8402640
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of pre-irradiation on monoclonal antibody localization in colon tumor xenografts expressing a cell-associated antigen.
    Gridley DS, Slater JB, Slater JM.
    Anticancer Res; 1995 Oct 01; 15(1):99-104. PubMed ID: 7733650
    [Abstract] [Full Text] [Related]

  • 27. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies.
    Kusano A, Ohta S, Shitara K, Hanai N.
    Anticancer Res; 1993 Oct 01; 13(6A):2207-12. PubMed ID: 8297135
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells.
    Herlyn D, Powe J, Ross AH, Herlyn M, Koprowski H.
    J Immunol; 1985 Feb 01; 134(2):1300-4. PubMed ID: 3965572
    [Abstract] [Full Text] [Related]

  • 29. Generation of human IgG, IgA, and IgM anti-melanoma monoclonal antibodies utilizing lymphocytes of an actively immunized melanoma patient.
    Abdel-wahab ZA, Gillanders WE, Darrow TL, Seigler HF.
    Hum Antibodies Hybridomas; 1992 Jan 01; 3(1):32-9. PubMed ID: 1576321
    [Abstract] [Full Text] [Related]

  • 30. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
    van Schaijk FG, Oosterwijk E, Molkenboer-Kuenen JD, Soede AC, McBride BJ, Goldenberg DM, Oyen WJ, Corstens FH, Boerman OC.
    J Nucl Med; 2005 Mar 01; 46(3):495-501. PubMed ID: 15750164
    [Abstract] [Full Text] [Related]

  • 31. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.
    Natali PG, Hamby CV, Felding-Habermann B, Liang B, Nicotra MR, Di Filippo F, Giannarelli D, Temponi M, Ferrone S.
    Cancer Res; 1997 Apr 15; 57(8):1554-60. PubMed ID: 9108459
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
    Reist CJ, Archer GE, Wikstrand CJ, Bigner DD, Zalutsky MR.
    Cancer Res; 1997 Apr 15; 57(8):1510-5. PubMed ID: 9108453
    [Abstract] [Full Text] [Related]

  • 38. Characterization of the colorectal carcinoma-associated antigen defined by monoclonal antibody D612.
    Fernsten PD, Primus FJ, Greiner JW, Simpson JF, Schlom J.
    Cancer Res; 1991 Feb 01; 51(3):926-34. PubMed ID: 1988133
    [Abstract] [Full Text] [Related]

  • 39. Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates.
    Schlom J, Eggensperger D, Colcher D, Molinolo A, Houchens D, Miller LS, Hinkle G, Siler K.
    Cancer Res; 1992 Mar 01; 52(5):1067-72. PubMed ID: 1310638
    [Abstract] [Full Text] [Related]

  • 40. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
    Carrel S, Schreyer M, Gross N, Zografos L.
    Anticancer Res; 1990 Mar 01; 10(1):81-9. PubMed ID: 1692197
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.